Fatemah Saleh Bin Saleh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fatemah Saleh Bin Saleh has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Abdul Rahman Jazieh
Cincinnati Cancer Advisors, Cincinnati, OH
1 shared publication - Abdulaziz A. Almusalam
Department of Family Medicine, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
1 shared publication - Abdullah E. Almanea
Ministry of National Guard Health Affairs, King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia
1 shared publication - Ahmed R. Alibrahim
Endocrinology and Metabolism, King Abdulaziz Medical City Riyadh, Riyadh, SAU
1 shared publication Aida Aldughaither
Family Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, SAU
1 shared publication- Aida Aldughaither
Department of Family Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 17 April 2026
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 26 (1)
Dietary and non-dietary complementary and alternative medicine use in Saudi Arabia: the differential role of associated factors
Complementary and alternative medicine (CAM) is widely used among cancer patients in Saudi Arabia. However, there is currently a lack of analysis of disagg
- 17 April 2026
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 26 (1)
Open AccessDietary and non-dietary complementary and alternative medicine use in Saudi Arabia: the differential role of associated factors
Complementary and alternative medicine (CAM) is widely used among cancer patients in Saudi Arabia. However, there is currently a lack of analysis of disagg
- Open Access
- 26 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (52) , e46758
Lipid metabolism in type 1 and type 2 diabetes: A comparative cross-sectional study
Types 1 and 2 diabetes mellitus (T1DM and T2DM, respectively) are chronic conditions with distinct pathophysiological mechanisms and clinical manifestations. Dyslipidemia is a common complication in both types, contributing to increased cardiovascular risk. This study aimed to compare the demographic and laboratory characteristics of patients with T1DM and T2DM in Saudi Arabia. We conducted 2 different studies both are retrospective cross-sectional studies that involved 409 T2DM and 509 T1DM patients, respectively. Data were collected from electronic medical records. Clinical characteristics, including diabetes duration, body mass index, hemoglobin A1C levels, and lipid profiles, were analyzed. Statistical comparisons were conducted to identify significant differences between the 2 groups. Patients with T2DM were older (mean age, 58.93 years) than those with T1DM (mean age, 26.15 years). Additionally, substantial demographic differences were observed between the 2 groups. Compared with patients with T2DM, who had hemoglobin A1C levels between 7% to 9%, patients with T1DM had worse glycemic control, with 55.8% of them having such values. Patients with T2DM were more likely to have obesity (63.6%) than those with T1DM (21.8%). Compared with patients with T2DM, those with T1DM had lower triglyceride levels but higher mean low-density lipoprotein, high-density lipoprotein, and total cholesterol levels. A considerably larger proportion of individuals with T2DM had aberrant triglyceride and low high-density lipoprotein levels, indicating a higher incidence of dyslipidemia. Patients with T1DM and T2DM have different clinical characteristics and lipid abnormalities. Patients with T2DM are at higher risk of dyslipidemia and related cardiovascular complications. To reduce cardiovascular risk in patients with diabetes, customized therapies that concentrate on lipid management and glycemic control are necessary. To manage dyslipidemia, further studies are necessary to investigate the underlying mechanisms and develop efficient treatment plans.
- 26 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (52) , e46758
Open AccessLipid metabolism in type 1 and type 2 diabetes: A comparative cross-sectional study
Types 1 and 2 diabetes mellitus (T1DM and T2DM, respectively) are chronic conditions with distinct pathophysiological mechanisms and clinical manifestations. Dyslipidemia is a common complication in both types, contributing to increased cardiovascular risk. This study aimed to compare the demographic and laboratory characteristics of patients with T1DM and T2DM in Saudi Arabia. We conducted 2 different studies both are retrospective cross-sectional studies that involved 409 T2DM and 509 T1DM patients, respectively. Data were collected from electronic medical records. Clinical characteristics, including diabetes duration, body mass index, hemoglobin A1C levels, and lipid profiles, were analyzed. Statistical comparisons were conducted to identify significant differences between the 2 groups. Patients with T2DM were older (mean age, 58.93 years) than those with T1DM (mean age, 26.15 years). Additionally, substantial demographic differences were observed between the 2 groups. Compared with patients with T2DM, who had hemoglobin A1C levels between 7% to 9%, patients with T1DM had worse glycemic control, with 55.8% of them having such values. Patients with T2DM were more likely to have obesity (63.6%) than those with T1DM (21.8%). Compared with patients with T2DM, those with T1DM had lower triglyceride levels but higher mean low-density lipoprotein, high-density lipoprotein, and total cholesterol levels. A considerably larger proportion of individuals with T2DM had aberrant triglyceride and low high-density lipoprotein levels, indicating a higher incidence of dyslipidemia. Patients with T1DM and T2DM have different clinical characteristics and lipid abnormalities. Patients with T2DM are at higher risk of dyslipidemia and related cardiovascular complications. To reduce cardiovascular risk in patients with diabetes, customized therapies that concentrate on lipid management and glycemic control are necessary. To manage dyslipidemia, further studies are necessary to investigate the underlying mechanisms and develop efficient treatment plans.
- Open Access
- 1 August 2022
- Published by Springer Nature in Cureus
- Vol. 14 (8) , e27573
Prevalence and Regulation of Dyslipidemia Among Adults With Type 2 Diabetes From Three Primary Health Care Centers in Riyadh
Dyslipidemia is an added risk factor in patients with type 2 diabetes who are more prone to develop cardiovascular diseases as it implies an alteration of the lipid level leading to serious health complications. This study aimed at assessing the prevalence of dyslipidemia among patients with type 2 diabetes and comparing the lipid profile measurements between controlled and uncontrolled type 2 diabetic patients. A cross-sectional retrospective study was performed in three primary health care centers in Saudi Arabia. A sample of 418 patients with type 2 diabetes was enrolled in this study. To collect data, the researcher used a structured questionnaire and retrieved patients' data from the electronic medical records in the study setting. The findings of the study showed that 82.1% of type 2 diabetes mellitus (DM) patients recruited in this study were dyslipidemic. In addition, it was found that there was a significant difference in triglycerides, fasting blood sugar (FBS), and high-density lipoprotein (HDL) between controlled and uncontrolled diabetic patients (p≤0.05). Moreover, a significant interaction was found between gender, HbA1c control, educational level, and frequency of exercising on one hand and dyslipidemia on the other hand (p≤0.05). The study concluded that there is a high prevalence of dyslipidemia among type 2 diabetic patients in Saudi Arabia and a significant interaction between dyslipidemia and diabetic patients' gender, HbA1c control, educational level, and frequency of exercising. The study recommends increasing type 2 diabetic patients' awareness regarding the management of diabetes and dyslipidemia and the importance of providing educational intervention regarding diabetes self-care activities.
- 1 August 2022
- Published by Springer Nature in Cureus
- Vol. 14 (8) , e27573
Open AccessPrevalence and Regulation of Dyslipidemia Among Adults With Type 2 Diabetes From Three Primary Health Care Centers in Riyadh
Dyslipidemia is an added risk factor in patients with type 2 diabetes who are more prone to develop cardiovascular diseases as it implies an alteration of the lipid level leading to serious health complications. This study aimed at assessing the prevalence of dyslipidemia among patients with type 2 diabetes and comparing the lipid profile measurements between controlled and uncontrolled type 2 diabetic patients. A cross-sectional retrospective study was performed in three primary health care centers in Saudi Arabia. A sample of 418 patients with type 2 diabetes was enrolled in this study. To collect data, the researcher used a structured questionnaire and retrieved patients' data from the electronic medical records in the study setting. The findings of the study showed that 82.1% of type 2 diabetes mellitus (DM) patients recruited in this study were dyslipidemic. In addition, it was found that there was a significant difference in triglycerides, fasting blood sugar (FBS), and high-density lipoprotein (HDL) between controlled and uncontrolled diabetic patients (p≤0.05). Moreover, a significant interaction was found between gender, HbA1c control, educational level, and frequency of exercising on one hand and dyslipidemia on the other hand (p≤0.05). The study concluded that there is a high prevalence of dyslipidemia among type 2 diabetic patients in Saudi Arabia and a significant interaction between dyslipidemia and diabetic patients' gender, HbA1c control, educational level, and frequency of exercising. The study recommends increasing type 2 diabetic patients' awareness regarding the management of diabetes and dyslipidemia and the importance of providing educational intervention regarding diabetes self-care activities.